JP2002531129A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002531129A5 JP2002531129A5 JP2000586916A JP2000586916A JP2002531129A5 JP 2002531129 A5 JP2002531129 A5 JP 2002531129A5 JP 2000586916 A JP2000586916 A JP 2000586916A JP 2000586916 A JP2000586916 A JP 2000586916A JP 2002531129 A5 JP2002531129 A5 JP 2002531129A5
- Authority
- JP
- Japan
- Prior art keywords
- clone
- seq
- trachomatis
- nos
- identified
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108700026244 Open Reading Frames Proteins 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 241000606153 Chlamydia trachomatis Species 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000692 anti-sense effect Effects 0.000 description 1
- 229940038705 chlamydia trachomatis Drugs 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/208,277 US6166177A (en) | 1998-12-08 | 1998-12-08 | Compounds and methods for the treatment and diagnosis of chlamydial infection |
| US09/208,277 | 1998-12-08 | ||
| US09/288,594 US6447779B1 (en) | 1998-12-08 | 1999-04-08 | Compounds for the diagnosis of Chlamydial infection |
| US09/288,594 | 1999-04-08 | ||
| US09/410,568 | 1999-10-01 | ||
| US09/410,568 US6555115B1 (en) | 1998-12-08 | 1999-10-01 | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US42657199A | 1999-10-22 | 1999-10-22 | |
| US09/426,571 | 1999-10-22 | ||
| PCT/US1999/029012 WO2000034483A2 (en) | 1998-12-08 | 1999-12-08 | Compounds and methods for treatment and diagnosis of chlamydial infection |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010209037A Division JP2011036258A (ja) | 1998-12-08 | 2010-09-17 | クラミジア感染の処置および診断のための化合物および方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002531129A JP2002531129A (ja) | 2002-09-24 |
| JP2002531129A5 true JP2002531129A5 (enExample) | 2010-06-03 |
Family
ID=27498718
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000586916A Pending JP2002531129A (ja) | 1998-12-08 | 1999-12-08 | クラミジア感染の処置および診断のための化合物および方法 |
| JP2010209037A Withdrawn JP2011036258A (ja) | 1998-12-08 | 2010-09-17 | クラミジア感染の処置および診断のための化合物および方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010209037A Withdrawn JP2011036258A (ja) | 1998-12-08 | 2010-09-17 | クラミジア感染の処置および診断のための化合物および方法 |
Country Status (18)
| Country | Link |
|---|---|
| EP (5) | EP2277892A3 (enExample) |
| JP (2) | JP2002531129A (enExample) |
| KR (4) | KR100829407B1 (enExample) |
| CN (1) | CN100365120C (enExample) |
| AT (1) | ATE469222T1 (enExample) |
| AU (2) | AU769293B2 (enExample) |
| BR (1) | BR9916020A (enExample) |
| CA (2) | CA2354232A1 (enExample) |
| DE (1) | DE69942426D1 (enExample) |
| ES (1) | ES2346832T3 (enExample) |
| HK (1) | HK1044020B (enExample) |
| HU (1) | HUP0400719A3 (enExample) |
| IL (5) | IL143531A0 (enExample) |
| MX (1) | MXPA01005813A (enExample) |
| NO (2) | NO20012812L (enExample) |
| NZ (1) | NZ512246A (enExample) |
| TR (1) | TR200102500T2 (enExample) |
| WO (1) | WO2000034483A2 (enExample) |
Families Citing this family (42)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7459524B1 (en) | 1997-10-02 | 2008-12-02 | Emergent Product Development Gaithersburg Inc. | Chlamydia protein, sequence and uses thereof |
| WO1999053948A1 (en) * | 1998-04-20 | 1999-10-28 | THE STATE OF OREGON, acting by and through THE STATE BOARD OF HIGHER EDUCATION, on behalf of OREGON STATE UNIVERSITY | Chlamydia proteins and their uses |
| AU5365999A (en) | 1998-08-20 | 2000-03-14 | Connaught Laboratories Limited | Nucleic acid molecules encoding pomp91a protein of (chlamydia) |
| AU5366099A (en) | 1998-08-20 | 2000-03-14 | Connaught Laboratories Limited | Nucleic acid molecules encoding inclusion membrane protein of (chlamydia) |
| US6686339B1 (en) | 1998-08-20 | 2004-02-03 | Aventis Pasteur Limited | Nucleic acid molecules encoding inclusion membrane protein C of Chlamydia |
| US6649370B1 (en) | 1998-10-28 | 2003-11-18 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| US6607730B1 (en) | 1998-11-02 | 2003-08-19 | Aventis Pasteur Limited/Aventis Pasteur Limitee | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| WO2000032784A1 (en) | 1998-12-01 | 2000-06-08 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| US6565856B1 (en) | 1998-12-08 | 2003-05-20 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US6447779B1 (en) | 1998-12-08 | 2002-09-10 | Corixa Corporation | Compounds for the diagnosis of Chlamydial infection |
| US20020061848A1 (en) * | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US6448234B1 (en) | 1998-12-08 | 2002-09-10 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US6432916B1 (en) | 1998-12-08 | 2002-08-13 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US6555115B1 (en) | 1998-12-08 | 2003-04-29 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| EP2277892A3 (en) | 1998-12-08 | 2011-04-27 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
| US7297341B1 (en) | 1998-12-23 | 2007-11-20 | Sanofi Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| US6808713B1 (en) | 1998-12-28 | 2004-10-26 | Aventis Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| NZ512448A (en) | 1998-12-28 | 2004-01-30 | Aventis Pasteur | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| GB9902555D0 (en) | 1999-02-05 | 1999-03-24 | Neutec Pharma Plc | Medicament |
| DE60041042D1 (de) | 1999-03-12 | 2009-01-22 | Aventis Pasteur | Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon |
| DE60036698T2 (de) | 1999-05-03 | 2008-07-24 | Sanofi Pasteur Ltd., Toronto | Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen |
| AU783547B2 (en) | 1999-09-20 | 2005-11-10 | Sanofi Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| US6632663B1 (en) | 1999-09-22 | 2003-10-14 | Aventis Pasteur Limited | DNA immunization against chlamydia infection |
| JP4864264B2 (ja) | 1999-12-22 | 2012-02-01 | サノフィ、パストゥール、リミテッド | クラミジア抗原および対応するｄｎａ断片ならびにその使用 |
| ATE389020T1 (de) | 2000-04-21 | 2008-03-15 | Corixa Corp | Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen |
| US6919187B2 (en) | 2000-04-21 | 2005-07-19 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| DE60125350T2 (de) | 2000-05-08 | 2007-07-12 | Sanofi Pasteur Ltd., Toronto | Chlamydia-antigene, entsprechende dns-fragmente und ihre verwendungen |
| ATE440861T1 (de) * | 2000-07-03 | 2009-09-15 | Novartis Vaccines & Diagnostic | Immunisierung gegen chlamydia pneumoniae |
| US7537772B1 (en) * | 2000-10-02 | 2009-05-26 | Emergent Product Development Gaithersburg Inc. | Chlamydia protein, gene sequence and the uses thereof |
| US7731980B2 (en) | 2000-10-02 | 2010-06-08 | Emergent Product Development Gaithersburg Inc. | Chlamydia PMP proteins, gene sequences and uses thereof |
| GB2378056A (en) * | 2001-07-27 | 2003-01-29 | William Dixon | Electrical connection device |
| ES2312649T3 (es) | 2001-12-12 | 2009-03-01 | Novartis Vaccines And Diagnostics S.R.L. | Inmunizacion frente a chlamydia trachomatis. |
| GB0203403D0 (en) | 2002-02-13 | 2002-04-03 | Chiron Spa | Chlamydia cytotoxic-T cell epitopes |
| JP2004261017A (ja) * | 2003-02-27 | 2004-09-24 | Arkray Inc | クラミジア・トラコマティスの検出方法およびそのためのキット |
| CA2602637A1 (en) * | 2005-03-31 | 2006-10-05 | Glaxosmithkline Biologicals Sa | Vaccines against chlamydial infection |
| US9259463B2 (en) * | 2006-01-16 | 2016-02-16 | The United States Of America, As Represented By The Secretary, Department Of Health & Human Services | Chlamydia vaccine |
| AU2007304199A1 (en) * | 2006-10-04 | 2008-04-10 | Corixa Corporation | Vaccines against Chlamydial infection |
| US20100310593A1 (en) * | 2007-06-14 | 2010-12-09 | Emergent Product Development Gaithersburg Inc. | Vaccines Against Chlamydia Infection |
| US8568732B2 (en) | 2009-03-06 | 2013-10-29 | Novartis Ag | Chlamydia antigens |
| US9458513B2 (en) | 2010-03-23 | 2016-10-04 | Wako Pure Chemical Industries, Ltd. | Primer and probe for detecting chlamydia trachomatis, and method for detecting chlamydia trachomatis using same |
| JP7146732B2 (ja) * | 2016-07-13 | 2022-10-04 | オハイオ ステート イノベーション ファウンデーション | 宿主抗原提示並びに宿主抗腫瘍及び抗病原体免疫を最適化するためのプラットフォーム及び方法 |
Family Cites Families (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4235877A (en) | 1979-06-27 | 1980-11-25 | Merck & Co., Inc. | Liposome particle containing viral or bacterial antigenic subunit |
| US4489710A (en) | 1981-06-23 | 1984-12-25 | Xoma Corporation | Composition and method for transplantation therapy |
| US4429008B1 (en) | 1981-12-10 | 1995-05-16 | Univ California | Thiol reactive liposomes |
| US4603112A (en) | 1981-12-24 | 1986-07-29 | Health Research, Incorporated | Modified vaccinia virus |
| US4769330A (en) | 1981-12-24 | 1988-09-06 | Health Research, Incorporated | Modified vaccinia virus and methods for making and using the same |
| US4671958A (en) | 1982-03-09 | 1987-06-09 | Cytogen Corporation | Antibody conjugates for the delivery of compounds to target sites |
| US4866034A (en) | 1982-05-26 | 1989-09-12 | Ribi Immunochem Research Inc. | Refined detoxified endotoxin |
| US4436727A (en) | 1982-05-26 | 1984-03-13 | Ribi Immunochem Research, Inc. | Refined detoxified endotoxin product |
| JPS59116229A (ja) | 1982-12-24 | 1984-07-05 | Teijin Ltd | 細胞毒性複合体を活性成分とする癌治療用剤およびその製造法 |
| US4673562A (en) | 1983-08-19 | 1987-06-16 | The Children's Medical Center Corporation | Bisamide bisthiol compounds useful for making technetium radiodiagnostic renal agents |
| US4873088A (en) | 1983-09-06 | 1989-10-10 | Liposome Technology, Inc. | Liposome drug delivery method and composition |
| US4625014A (en) | 1984-07-10 | 1986-11-25 | Dana-Farber Cancer Institute, Inc. | Cell-delivery agent |
| US4542225A (en) | 1984-08-29 | 1985-09-17 | Dana-Farber Cancer Institute, Inc. | Acid-cleavable compound |
| US4918164A (en) | 1987-09-10 | 1990-04-17 | Oncogen | Tumor immunotherapy using anti-idiotypic antibodies |
| US4638045A (en) | 1985-02-19 | 1987-01-20 | Massachusetts Institute Of Technology | Non-peptide polyamino acid bioerodible polymers |
| US4751180A (en) | 1985-03-28 | 1988-06-14 | Chiron Corporation | Expression using fused genes providing for protein product |
| GB8508845D0 (en) | 1985-04-04 | 1985-05-09 | Hoffmann La Roche | Vaccinia dna |
| US4777127A (en) | 1985-09-30 | 1988-10-11 | Labsystems Oy | Human retrovirus-related products and methods of diagnosing and treating conditions associated with said retrovirus |
| US4935233A (en) | 1985-12-02 | 1990-06-19 | G. D. Searle And Company | Covalently linked polypeptide cell modulators |
| US4699784A (en) | 1986-02-25 | 1987-10-13 | Center For Molecular Medicine & Immunology | Tumoricidal methotrexate-antibody conjugate |
| US4877611A (en) | 1986-04-15 | 1989-10-31 | Ribi Immunochem Research Inc. | Vaccine containing tumor antigens and adjuvants |
| US5075109A (en) | 1986-10-24 | 1991-12-24 | Southern Research Institute | Method of potentiating an immune response |
| GB8702816D0 (en) | 1987-02-07 | 1987-03-11 | Al Sumidaie A M K | Obtaining retrovirus-containing fraction |
| US4735792A (en) | 1987-04-28 | 1988-04-05 | The United States Of America As Represented By The United States Department Of Energy | Radioiodinated maleimides and use as agents for radiolabeling antibodies |
| US4897268A (en) | 1987-08-03 | 1990-01-30 | Southern Research Institute | Drug delivery system and method of making the same |
| WO1989001973A2 (en) | 1987-09-02 | 1989-03-09 | Applied Biotechnology, Inc. | Recombinant pox virus for immunization against tumor-associated antigens |
| AP129A (en) | 1988-06-03 | 1991-04-17 | Smithkline Biologicals S A | Expression of retrovirus gag protein eukaryotic cells |
| US4912094B1 (en) | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
| EP1645635A3 (en) | 1989-08-18 | 2010-07-07 | Oxford Biomedica (UK) Limited | Replication defective recombinant retroviruses expressing a palliative |
| SE466259B (sv) | 1990-05-31 | 1992-01-20 | Arne Forsgren | Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal |
| EP0761231B1 (en) | 1992-06-25 | 2000-01-12 | SMITHKLINE BEECHAM BIOLOGICALS s.a. | Vaccine composition containing adjuvants |
| US5359681A (en) | 1993-01-11 | 1994-10-25 | University Of Washington | Fiber optic sensor and methods and apparatus relating thereto |
| US5840297A (en) * | 1993-03-19 | 1998-11-24 | Johns Hopkins University | Vaccine comprising anti-idiotypic antibody to chlamydia GLXA and process |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| EP0772619B2 (en) | 1994-07-15 | 2010-12-08 | The University of Iowa Research Foundation | Immunomodulatory oligonucleotides |
| EP2045261A1 (en) * | 1994-09-20 | 2009-04-08 | Hitachi Chemical Co., Ltd. | Chlamydia pneumoniae antigenic polypeptides |
| AU3876795A (en) * | 1994-11-17 | 1996-06-17 | Maxim Pharmaceuticals, Inc. | Immunogens for stimulating mucosal immunity |
| UA56132C2 (uk) | 1995-04-25 | 2003-05-15 | Смітклайн Бічем Байолоджікалс С.А. | Композиція вакцини (варіанти), спосіб стабілізації qs21 відносно гідролізу (варіанти), спосіб приготування композиції вакцини |
| EP0832282A1 (en) | 1995-06-02 | 1998-04-01 | Incyte Pharmaceuticals, Inc. | IMPROVED METHOD FOR OBTAINING FULL-LENGTH cDNA SEQUENCES |
| WO1997024447A1 (en) | 1996-01-02 | 1997-07-10 | Chiron Corporation | Immunostimulation mediated by gene-modified dendritic cells |
| EP0915978B1 (en) * | 1996-07-12 | 2005-12-14 | University of Manitoba | Dna immunization against chlamydia infection |
| US6464979B1 (en) * | 1996-09-12 | 2002-10-15 | Aventis Pasteur Limited | Chlamydial vaccines and methods of preparation thereof |
| BR9814878A (pt) | 1997-11-21 | 2000-10-03 | Genset Sa | Sequência genÈmica e polipeptìdeos de chlamydia pneumoniae, fragmentos dos mesmos e usos dos mesmos, em particular para o diagnóstico, a prevenção e o tratamento de infecção |
| BR9814912A (pt) * | 1997-11-28 | 2000-10-03 | Genset Sa | Sequência genÈmica e polipeptìdeos de chlamydia trachomatis, fragmentos dos mesmos e usos dos mesmos, em particular para o diagnóstico, a prevenção e o tratamento de infecção |
| AU5297399A (en) * | 1998-08-20 | 2000-03-14 | Aventis Pasteur Limited | (chlamydia) antigens and corresponding dna fragments and uses thereof |
| EP1133572A4 (en) | 1998-11-12 | 2005-06-15 | Univ California | GENOMIC SEQUENCE OF CHLAMYDIA PNEUMONIAE |
| US6565856B1 (en) | 1998-12-08 | 2003-05-20 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| EP2277892A3 (en) | 1998-12-08 | 2011-04-27 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US20020061848A1 (en) | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
| GB9902555D0 (en) | 1999-02-05 | 1999-03-24 | Neutec Pharma Plc | Medicament |
| DE60036698T2 (de) | 1999-05-03 | 2008-07-24 | Sanofi Pasteur Ltd., Toronto | Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen |
| AU783547B2 (en) | 1999-09-20 | 2005-11-10 | Sanofi Pasteur Limited | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| US6632663B1 (en) | 1999-09-22 | 2003-10-14 | Aventis Pasteur Limited | DNA immunization against chlamydia infection |
| CA2388461C (en) * | 1999-09-28 | 2013-06-11 | Infectio Diagnostic (I.D.I.) Inc. | Highly conserved genes and their use to generate probes and primers for the detection of microorganisms |
| JP4864264B2 (ja) | 1999-12-22 | 2012-02-01 | サノフィ、パストゥール、リミテッド | クラミジア抗原および対応するｄｎａ断片ならびにその使用 |
| ATE389020T1 (de) | 2000-04-21 | 2008-03-15 | Corixa Corp | Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen |
| DE60125350T2 (de) | 2000-05-08 | 2007-07-12 | Sanofi Pasteur Ltd., Toronto | Chlamydia-antigene, entsprechende dns-fragmente und ihre verwendungen |
| ATE440861T1 (de) | 2000-07-03 | 2009-09-15 | Novartis Vaccines & Diagnostic | Immunisierung gegen chlamydia pneumoniae |
| US9103184B2 (en) | 2013-03-08 | 2015-08-11 | Tejas Research & Engineering, Llc | Inflow control valve |
| WO2016023894A1 (en) | 2014-08-11 | 2016-02-18 | U3 Pharma Gmbh | Human anti-fgfr4 antibody |
-
1999
- 1999-12-08 EP EP10179022A patent/EP2277892A3/en not_active Withdrawn
- 1999-12-08 JP JP2000586916A patent/JP2002531129A/ja active Pending
- 1999-12-08 WO PCT/US1999/029012 patent/WO2000034483A2/en not_active Ceased
- 1999-12-08 CN CNB998157236A patent/CN100365120C/zh not_active Expired - Fee Related
- 1999-12-08 NZ NZ512246A patent/NZ512246A/en not_active IP Right Cessation
- 1999-12-08 IL IL14353199A patent/IL143531A0/xx unknown
- 1999-12-08 ES ES99963037T patent/ES2346832T3/es not_active Expired - Lifetime
- 1999-12-08 EP EP99963037A patent/EP1144642B1/en not_active Expired - Lifetime
- 1999-12-08 HU HU0400719A patent/HUP0400719A3/hu unknown
- 1999-12-08 TR TR2001/02500T patent/TR200102500T2/xx unknown
- 1999-12-08 KR KR1020017007165A patent/KR100829407B1/ko not_active Expired - Fee Related
- 1999-12-08 AU AU19358/00A patent/AU769293B2/en not_active Ceased
- 1999-12-08 EP EP10179569A patent/EP2277893A3/en not_active Withdrawn
- 1999-12-08 AT AT99963037T patent/ATE469222T1/de not_active IP Right Cessation
- 1999-12-08 MX MXPA01005813A patent/MXPA01005813A/es active IP Right Grant
- 1999-12-08 HK HK02105516.2A patent/HK1044020B/zh not_active IP Right Cessation
- 1999-12-08 CA CA002354232A patent/CA2354232A1/en not_active Abandoned
- 1999-12-08 KR KR1020107027275A patent/KR20100132086A/ko not_active Abandoned
- 1999-12-08 DE DE69942426T patent/DE69942426D1/de not_active Expired - Lifetime
- 1999-12-08 BR BR9916020-0A patent/BR9916020A/pt not_active Application Discontinuation
- 1999-12-08 EP EP10163839A patent/EP2223935A3/en not_active Withdrawn
- 1999-12-08 KR KR1020077022107A patent/KR20070108263A/ko not_active Ceased
- 1999-12-08 CA CA2746535A patent/CA2746535A1/en not_active Abandoned
- 1999-12-08 EP EP10163838A patent/EP2218733A1/en not_active Withdrawn
- 1999-12-08 KR KR1020097016159A patent/KR20090088972A/ko not_active Ceased
-
2001
- 2001-06-07 NO NO20012812A patent/NO20012812L/no not_active Application Discontinuation
-
2004
- 2004-04-22 AU AU2004201702A patent/AU2004201702B2/en not_active Ceased
-
2010
- 2010-09-14 NO NO20101293A patent/NO20101293L/no not_active Application Discontinuation
- 2010-09-17 JP JP2010209037A patent/JP2011036258A/ja not_active Withdrawn
- 2010-11-04 IL IL209116A patent/IL209116A0/en unknown
- 2010-11-04 IL IL209114A patent/IL209114A0/en unknown
- 2010-11-04 IL IL209113A patent/IL209113A0/en unknown
- 2010-11-04 IL IL209115A patent/IL209115A0/en unknown